NCT05680532 (BR) is a NA clinical trial of Black raspberry in Alzheimer Disease, sponsored by Chung Shan Medical University.

Who is sponsoring NCT05680532?

NCT05680532 is sponsored by Chung Shan Medical University.

What drugs are being tested in NCT05680532?

Interventions in NCT05680532: Black raspberry, Placebo.

What condition does NCT05680532 study?

NCT05680532 studies Alzheimer Disease, H Pylori Infection.

Is NCT05680532 still recruiting?

NCT05680532 is currently completed. Last updated 11 January 2023.

Last reviewed 2023-01-11 · How we verify

NCT05680532: BR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Improvement of Black Raspberry in Obese and Mild AZ Patients Infected With H. Pylori

Completed NA Last updated 11 January 2023

What this trial tests

NA trial testing Black raspberry in Alzheimer Disease in 21 participants. Completed in 4 August 2022.

Timeline

11 November 2021

Primary endpoint
5 June 2022

4 August 2022

Quick facts

Lead sponsor	Chung Shan Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	21
Start date	11 November 2021
Primary completion	5 June 2022
Estimated completion	4 August 2022
Sites	1 location across Taiwan

Drugs / interventions tested

Black raspberry — full drug profile →
Placebo

Conditions studied

Alzheimer Disease — all drugs for Alzheimer Disease →
H Pylori Infection — all drugs for H Pylori Infection →

Sponsor

Chung Shan Medical University

Who can join

Adults 20 to 80, any sex, with Alzheimer Disease or H Pylori Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study was designed to check the impact of black raspberry (BR) on obese and mild Alzheimers (AZ) patients infected with Helicobacter pylori (H pylori). Through checking various parameters including anthropometric, antioxidants, and CDR.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Black raspberry supplementation on overweight and Helicobacter pylori infected mild dementia patients a pilot study.
Tandoro Y, Chiu HF, Tan CL, Hsieh MH, et al · · 2025 · cited 1× · PMID 39939643 · DOI 10.1038/s41538-024-00356-w
Dietary Black Raspberry Supplementation as Natural Polyphenol Source Against Mild Dementia Patients with Overweight and Helicobacter pylori Infection
Wang C, Tandoro Y, Chiu H, Tan C, et al · · 2024 · DOI 10.21203/rs.3.rs-3899398/v1

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other Chung Shan Medical University trials

Trials by the same sponsor.

NCT07443540 — The Effect of Acupuncture on Pulmonary Function Recovery Following Lung Resection · NA · not yet recruiting
NCT07504029 — Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides · NA · recruiting
NCT07252557 — Mouthwash Temperature and Oral Mucositis in Head and Neck Radiotherapy · NA · not yet recruiting
NCT07282496 — Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial · NA · not yet recruiting
NCT07504016 — Development of a Novel Cookie Formulation and Evaluation of Its Effects on Glycemic Control in Healthy Individuals · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05680532 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chung Shan Medical University
Last refreshed: 11 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05680532.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing